Blog
RSS FeedPosted by Michael Wonder on 23 Apr 2024
More treatment options proposed for people with multiple myeloma and myelodysplastic syndrome
23 April 2024 - PHARMAC is proposing to fund more treatments for people with a type of blood cancer, multiple ...
Posted by Michael Wonder on 22 Apr 2024
Alvotech signs US agreement to expand access for newly approved high concentration interchangeable biosimilar to Humira (adalimumab)
19 April 2024 - Alvotech, in agreement with Teva Pharmaceuticals, has signed an agreement with a strategic partner to bring to ...
Posted by Michael Wonder on 22 Apr 2024
Boost for pharmacists for flu season
20 April 2024 - The Albanese Government is protecting Australians in aged care and disability homes by funding pharmacists for the ...
Posted by Michael Wonder on 19 Apr 2024
National pharmacare will reduce access to new medicines for 27 million privately insured Canadians
18 April 2024 - The federal Liberal-NDP coalition government recently announced it would work with the provinces to fund universal prescription ...
Posted by Michael Wonder on 19 Apr 2024
Publication of Stage 1 and Stage 2 PBS Process Improvements metrics report for 2022-23
19 April 2024 - The 2022-23 Stage 1 and Stage 2 PBS process improvements metrics report is now available on ...
Posted by Michael Wonder on 18 Apr 2024
PHARMAC's perpetually stretched budget
18 April 2024 - PHARMAC holds the keys to New Zealand's medicine cabinet, and what it dishes out is never enough. ...
Posted by Michael Wonder on 12 Apr 2024
More treatments available to 30,000 New Zealanders
12 April 2024 - PHARMAC has decided to fund several medicines and widen access to two others, a move that will ...
Posted by Michael Wonder on 12 Apr 2024
Formycon announces commercial launch of FYB201 (ranibizumab) in Canada (Ranopto) and Switzerland (Ranivisio)
11 April 2024 - Commercialization partner Teva markets FYB201 in Canada under the trademark Ranopto and in Switzerland under the trademark ...
Posted by Michael Wonder on 12 Apr 2024
Waiting for new medicines in Canada, Europe, and the United States: study finds Americans get better and faster access to innovative drugs
11 April 2024 - A recent study published by the Canadian Health Policy Institute examined the availability and wait times ...
Posted by Michael Wonder on 11 Apr 2024
'Really expensive': migraine expert calls for more funded treatments
10 April 2024 - Migraine experts are advocating for PHARMAC to fund a new generation of migraine drugs that target ...
Posted by Michael Wonder on 10 Apr 2024
Why won’t health insurance companies pay for new drugs?
10 April 2024 - The FDA is doing its part to fast-track new treatments, but insurers are standing in the way ...
Posted by Michael Wonder on 10 Apr 2024
New target zero initiative aims to help improve access to new drugs
9 April 2024 - Target Zero is a new initiative that aims to improve the time to access for patients ...
Posted by Michael Wonder on 10 Apr 2024
Calls for supplement to treat rare metabolic disorder to be relisted on PBS
10 April 2024 - An Adelaide mother says a vital supplement that assists her sons with a rare metabolic disorder ...
Posted by Michael Wonder on 10 Apr 2024
Mum’s plea: ‘I’m dying but $7.70 could save my kids’
10 April 2024 - Amelia Ramsay has battled all her life – and now she may have to watch her kids ...
Posted by Michael Wonder on 08 Apr 2024
Australians benefit from cheaper medicines on the PBS
8 April 2024 - Australians with high cholesterol, chronic kidney disease and ovarian cancer now have access to cheaper medicines under ...